Thank you
Thank you for joining us today. Industry Innovations Webinars are archived on the ATS YouTube channel under the Industry Innovation playlist. https://www.youtube.com/playlist?list=PLFyO68a-Ji3n0xo20dmiQGvtDk9e2dKeH
Expect a brief satisfaction survey via email. Your feedback is appreciated as it helps improve programming for the future.
Description
Despite multiple treatment options, patients with PAH still
face a devastating and progressive disease. This program will focus on
the imbalances in BMPR2 and activin receptor signaling that may drive PAH
progression, reviewing the latest data available. A new therapeutic
approach that aims to rebalance this signaling will be discussed in the context
of potential disease modification.
This program is sponsored by Acceleron.
By registering for this
webinar, you agree your information will be shared with the sponsor.
No CME or MOC credits are
available for this program.
Opinions expressed and
resources shared may not have been reviewed by the ATS prior to distribution
through ATS channels, or reflect official positions of the ATS, unless it is
explicitly noted as a result of official ATS approval. References to specific commercial
entities (companies) or products do not reflect review or endorsement by the
ATS unless it is explicitly noted as a result of official ATS approval.